Dr. Ullrich Schwertschlag is an accomplished internist, pharmacologist and clinical pharmacologist with over thirty years of experience in the biopharmaceutical industry including large pharmaceutical and small biotech companies. He has been a principal investigator in phase 1 studies, attending physician and basic researcher in academic settings and the VA.

Dr. Schwertschlag has been decisive and successful in design, implementation and analysis of clinical development programs in the US and Europe from phase 1 – 3. Creative in translational research, as well as preclinical and clinical development of drugs/biologicals in major disease areas including oncology, immunology and neurology. Leading roles as author of over 40 INDs, 3 BLA/NDAs and interactions/presentations with the FDA. Leading author of many study reports, safety reviews, advisory board presentations and peer reviewed publications. Author/Principal Investigator of several small business grants.

Specialties include clinical drug development, translational medicine and discovery medicine.